Triple-negative breast cancer (TNBC) is an especially aggressive subtype characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/ERBB2)2. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.